Stockreport

Candel Therapeutics GAAP EPS of -$0.21 misses by $0.03 [Seeking Alpha]

Candel Therapeutics, Inc.  (CADL) 
PDF More on Candel Therapeutics Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now Candel Therapeutics: Potentially The Next Exciting Oncology Sto [Read more]